The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Quantitative screening of advanced glycation endproducts in cellular and extracellular proteins by tandem mass spectrometry
Open accessAbstract
Glycation of proteins forms fructosamines and advanced glycation endproducts. Glycation adducts may be risk markers and risk factors of disease development. We measured the concentrations of the early glycation adduct fructosyl-lysine and 12 advanced glycation endproducts by liquid chromatography with tandem mass spectrometric detection. Underivatized analytes were detected free in physiological fluids and in enzymic hydrolysates of cellular and extracellular proteins. Hydroimidazolones were the most important glycation biomarkers quantitatively; monolysyl adducts (Nε-carboxymethyl-lysine and Nε-1-carboxyethyl-lysine) were found in moderate amounts, and bis(lysyl)imidazolium cross-links and pentosidine in lowest amounts. Quantitative screening showed high levels of advanced glycation endproducts in cellular protein and moderate levels in protein of blood plasma. Glycation adduct accumulation in tissues depended on the particular adduct and tissue type. Low levels of free advanced glycation endproducts were found in blood plasma and levels were 10–100-fold higher in urine. Advanced glycation endproduct residues were increased in blood plasma and at sites of vascular complications development in experimental diabetes; renal glomeruli, retina and peripheral nerve. In clinical uraemia, the concentrations of plasma protein advanced glycation endproduct residues increased 1–7-fold and free adduct concentrations increased up to 50-fold. Comprehensive screening of glycation adducts revealed the relative and quantitative importance of α-oxoaldehyde-derived advanced glycation endproducts in physiological modification of proteins–particularly hydroimidazolones, the efficient renal clearance of free adducts, and the marked increases of glycation adducts in diabetes and uraemia–particularly free advanced glycation endproducts in uraemia. Increased levels of these advanced glycation endproducts were associated with vascular complications in diabetes and uraemia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Biochemistry and molecular cell biology of diabetic complications
Brownlee, M. (2001) · Nature · doi:10.1038/414813a · Cited by 9,107
The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses
Schmidt, A. M., Yan, S. D., Yan, S. F., & Stern, D. M. (2001) · Journal of Clinical Investigation · doi:10.1172/jci14002 · Cited by 1,253
Effect of Collagen Turnover on the Accumulation of Advanced Glycation End Products
Verzijl, N., DeGroot, J., Thorpe, S. R., Bank, R. A., Shaw, J. N., Lyons, T. J., Bijlsma, J. W. J., Lafeber, F. P. J. G., Baynes, J. W., & TeKoppele, J. M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m006700200 · Cited by 963
Hammes, H.-P., Du, X., Edelstein, D., Taguchi, T., Matsumura, T., Ju, Q., Lin, J., Bierhaus, A., Nawroth, P., Hannak, D., et al. (2003) · Nature Medicine · doi:10.1038/nm834 · Cited by 785
Tetranitromethane. A Reagent for the Nitration of Tyrosyl Residues in Proteins*
Sokolovsky, M., Riordan, J. F., & Vallee, B. L. (1966) · Biochemistry · doi:10.1021/bi00875a029 · Cited by 637
Glyoxalase System in Clinical Diabetes Mellitus and Correlation with Diabetic Complications
McLellan, A. C., Thornalley, P. J., Benn, J., & Sonksen, P. H. (1994) · Clinical Science · doi:10.1042/cs0870021 · Cited by 557
Self-citationShinohara, M., Thornalley, P. J., Giardino, I., Beisswenger, P., Thorpe, S. R., Onorato, J., & Brownlee, M. (1998) · Journal of Clinical Investigation · doi:10.1172/jci119885 · Cited by 513
Self-citationThornalley, P. J. (1998) · PubMed · Cited by 387
Self-citationPrevention of Incipient Diabetic Nephropathy by High-Dose Thiamine and Benfotiamine
Babaei-Jadidi, R., Karachalias, N., Ahmed, N., Battah, S., & Thornalley, P. J. (2003) · Diabetes · doi:10.2337/diabetes.52.8.2110 · Cited by 373
Self-citationReactive glycosylation endproducts in diabetic uraemia and treatment of renal failure
Makita, Z., Bucala, R., Rayfield, E. J., Fuh, H., Manogue, K. R., Cerami, A., Viassara, H., Friedman, E. A., Kaufman, A. M., Korbet, S. M., et al. (1994) · The Lancet · doi:10.1016/s0140-6736(94)92935-1 · Cited by 373
Cited by
Advanced glycation endproducts in food and their effects on health
Poulsen, M. W., Hedegaard, R. V., Andersen, J. M., de Courten, B., Bügel, S., Nielsen, J., Skibsted, L. H., & Dragsted, L. O. (2013) · Food and Chemical Toxicology · doi:10.1016/j.fct.2013.06.052 · Cited by 751
Chaudhuri, J., Bains, Y., Guha, S., Kahn, A., Hall, D., Bose, N., Gugliucci, A., & Kapahi, P. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.08.014 · Cited by 669
“Unfortunately, the trial was discontinued due to side effects (Thornalley, 2003), which has led to reduced enthusiasm in the field that lowering AGEs would be a successful strategy in treating age-related diseases.”
BackgroundSchalkwijk, C. G., & Stehouwer, C. D. A. (2020) · Physiological Reviews · doi:10.1152/physrev.00001.2019 · Cited by 622
Molecular and Cellular Mechanisms of Cardiovascular Disorders in Diabetes
Shah, M. S., & Brownlee, M. (2016) · Circulation Research · doi:10.1161/circresaha.116.306923 · Cited by 602
Tomlinson, D. R., & Gardiner, N. J. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2294 · Cited by 564
Quantification of protein modification by oxidants
Hawkins, C. L., Morgan, P. E., & Davies, M. J. (2009) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2009.01.007 · Cited by 487
Thornalley (2008) · Drug Metabolism and Drug Interactions · doi:10.1515/dmdi.2008.23.1-2.125 · Cited by 480
Baking, Ageing, Diabetes: A Short History of the Maillard Reaction
Hellwig, M., & Henle, T. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201308808 · Cited by 467
Dicarbonyl Intermediates in the Maillard Reaction
THORNALLEY, P. J. (2005) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1333.014 · Cited by 459
Self-citationThe glycation of albumin: Structural and functional impacts
Rondeau, P., & Bourdon, E. (2011) · Biochimie · doi:10.1016/j.biochi.2010.12.003 · Cited by 433
Methylglyoxal, glyoxalase 1 and the dicarbonyl proteome
Rabbani, N., & Thornalley, P. J. (2012) · Amino Acids · doi:10.1007/s00726-010-0783-0 · Cited by 430
Self-citationGenuth, S., Sun, W., Cleary, P., Sell, D. R., Dahms, W., Malone, J., Sivitz, W., Monnier, V. M., & for the DCCT Skin Collagen Ancillary Study Group (2005) · Diabetes · doi:10.2337/diabetes.54.11.3103 · Cited by 427
Zhang, Q., Ames, J. M., Smith, R. D., Baynes, J. W., & Metz, T. O. (2009) · Journal of Proteome Research · doi:10.1021/pr800858h · Cited by 421
Hyperglycemia and Glycation in Diabetic Complications
Negre-Salvayre, A., Salvayre, R., Augé, N., Pamplona, R., & Portero-Otín, M. (2009) · Antioxidants & Redox Signaling · doi:10.1089/ars.2009.2484 · Cited by 421
Review: Glycation of human serum albumin
Anguizola, J., Matsuda, R., Barnaby, O. S., Hoy, K. S., Wa, C., DeBolt, E., Koke, M., & Hage, D. S. (2013) · Clinica Chimica Acta · doi:10.1016/j.cca.2013.07.013 · Cited by 395
Advanced glycation endproducts: what is their relevance to diabetic complications?
Ahmed, N., & Thornalley, P. J. (2007) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2006.00595.x · Cited by 371
Self-citationRosca, M. G., Mustata, T. G., Kinter, M. T., Ozdemir, A. M., Kern, T. S., Szweda, L. I., Brownlee, M., Monnier, V. M., & Weiss, M. F. (2005) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00415.2004 · Cited by 354
Role of advanced glycation end products in cardiovascular disease
Hegab, Z. (2012) · World Journal of Cardiology · doi:10.4330/wjc.v4.i4.90 · Cited by 354
Chemopreventive effects of natural dietary compounds on cancer development
Pan, M.-H., & Ho, C.-T. (2008) · Chemical Society Reviews · doi:10.1039/b801558a · Cited by 346
Pattison, D. I., & Davies, M. J. (2006) · Biochemistry · doi:10.1021/bi060348s · Cited by 338
The role of methylglyoxal and the glyoxalase system in diabetes and other age-related diseases
Maessen, D. E. M., Stehouwer, C. D. A., & Schalkwijk, C. G. (2015) · Clinical Science · doi:10.1042/cs20140683 · Cited by 334
Ahmed, N., Dobler, D., Dean, M., & Thornalley, P. J. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m410973200 · Cited by 314
Self-citationXue, M., Rabbani, N., Momiji, H., Imbasi, P., Anwar, M. M., Kitteringham, N., Park, B. K., Souma, T., Moriguchi, T., Yamamoto, M., et al. (2012) · Biochemical Journal · doi:10.1042/bj20111648 · Cited by 302
Self-citationMorcos, M., Du, X., Pfisterer, F., Hutter, H., Sayed, A. A. R., Thornalley, P., Ahmed, N., Baynes, J., Thorpe, S., Kukudov, G., et al. (2008) · Aging Cell · doi:10.1111/j.1474-9726.2008.00371.x · Cited by 274
Self-citationDobler, D., Ahmed, N., Song, L., Eboigbodin, K. E., & Thornalley, P. J. (2006) · Diabetes · doi:10.2337/db05-1634 · Cited by 270
Self-citationRabbani, N., & Thornalley, P. J. (2014) · Nature Protocols · doi:10.1038/nprot.2014.129 · Cited by 265
Self-citationThe Chemistry of Protein Oxidation in Food
Hellwig, M. (2019) · Angewandte Chemie International Edition · doi:10.1002/anie.201814144 · Cited by 259
Structural Basis for Pattern Recognition by the Receptor for Advanced Glycation End Products (RAGE)
Xie, J., Reverdatto, S., Frolov, A., Hoffmann, R., Burz, D. S., & Shekhtman, A. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m801622200 · Cited by 252
Age-related muscle dysfunction
Thompson, L. V. (2009) · Experimental Gerontology · doi:10.1016/j.exger.2008.05.003 · Cited by 226
Susztak, K., Ciccone, E., McCue, P., Sharma, K., & Böttinger, E. P. (2005) · PLoS Medicine · doi:10.1371/journal.pmed.0020045 · Cited by 214
Assar, S. H., Moloney, C., Lima, M., Magee, R., & Ames, J. M. (2009) · Amino Acids · doi:10.1007/s00726-008-0071-4 · Cited by 206
“A number of isotope dilution LC-MS/MS methods have been reported for the quantification of CML in biological matrices in recent years (Thornalley et al. 2003; Teerlink et al. 2004; Delatour et al. 2006; Fenaille et al. 2006; Schettgen et al. 2007).”
MethodResultInfluentialUchiki, T., Weikel, K. A., Jiao, W., Shang, F., Caceres, A., Pawlak, D., Handa, J. T., Brownlee, M., Nagaraj, R., & Taylor, A. (2012) · Aging Cell · doi:10.1111/j.1474-9726.2011.00752.x · Cited by 200
“Age-related modification of proteins by sugars or potent glycating sugar metabolites, such as MGO, results in formation of AGEs such as hydroimidazolone adducts (MG-H1) (Brownlee, 2001; Thornalley et al., 2003; Pawlak et al., 2004).”
BackgroundMischak, H., Coon, J. J., Novak, J., Weissinger, E. M., Schanstra, J. P., & Dominiczak, A. F. (2009) · Mass Spectrometry Reviews · doi:10.1002/mas.20205 · Cited by 193
Maillard-Lefebvre, H., Boulanger, E., Daroux, M., Gaxatte, C., Hudson, B. I., & Lambert, M. (2009) · Rheumatology · doi:10.1093/rheumatology/kep199 · Cited by 190
Pathways of the Maillard reaction under physiological conditions
Henning, C., & Glomb, M. A. (2016) · Glycoconjugate Journal · doi:10.1007/s10719-016-9694-y · Cited by 189
Xue, J., Ray, R., Singer, D., Böhme, D., Burz, D. S., Rai, V., Hoffmann, R., & Shekhtman, A. (2014) · Biochemistry · doi:10.1021/bi500046t · Cited by 186
Dicarbonyls and glyoxalase in disease mechanisms and clinical therapeutics
Rabbani, N., Xue, M., & Thornalley, P. J. (2016) · Glycoconjugate Journal · doi:10.1007/s10719-016-9705-z · Cited by 169
Self-citationDicarbonyl proteome and genome damage in metabolic and vascular disease
Rabbani, N., & Thornalley, P. J. (2014) · Biochemical Society Transactions · doi:10.1042/bst20140018 · Cited by 140
Self-citationKoska, J., Saremi, A., Howell, S., Bahn, G., De Courten, B., Ginsberg, H., Beisswenger, P. J., Reaven, P. D., & for the VADT Investigators (2018) · Diabetes Care · doi:10.2337/dc17-1740 · Cited by 134
Thornalley, P. J., & Rabbani, N. (2014) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2013.03.025 · Cited by 133
Self-citationRabbani, N., Sebekova, K., Sebekova, K., Heidland, A., & Thornalley, P. J. (2007) · Kidney International · doi:10.1038/sj.ki.5002513 · Cited by 90
Self-citation3-Nitrotyrosine quantification methods: Current concepts and future challenges
Teixeira, D., Fernandes, R., Prudêncio, C., & Vieira, M. (2016) · Biochimie · doi:10.1016/j.biochi.2016.02.011 · Cited by 90
Kidney, heart and brain: three organs targeted by ageing and glycation
Frimat, M., Daroux, M., Litke, R., Nevière, R., Tessier, F. J., & Boulanger, E. (2017) · Clinical Science · doi:10.1042/cs20160823 · Cited by 88
Mass spectrometry and 3‐nitrotyrosine: Strategies, controversies, and our current perspective
Tsikas, D., & Duncan, M. W. (2014) · Mass Spectrometry Reviews · doi:10.1002/mas.21396 · Cited by 76
Mastrocola, R., Collino, M., Rogazzo, M., Medana, C., Nigro, D., Boccuzzi, G., & Aragno, M. (2013) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00450.2012 · Cited by 63
Poulsen, M. W., Bak, M. J., Andersen, J. M., Monošík, R., Giraudi-Futin, A. C., Holst, J. J., Nielsen, J., Lauritzen, L., Larsen, L. H., Bügel, S., et al. (2014) · European Journal of Nutrition · doi:10.1007/s00394-013-0574-y · Cited by 55
Glycation free adduct accumulation in renal disease: the new AGE
Thornalley, P. J. (2005) · Pediatric Nephrology · doi:10.1007/s00467-005-2011-9 · Cited by 53
Rabbani, N., & Thornalley, P. J. (2008) · Methods in Enzymology · doi:10.1016/s0076-6879(07)00822-1 · Cited by 32
Self-citationBaldensperger, T., Jost, T., Zipprich, A., & Glomb, M. A. (2018) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.7b05813 · Cited by 31
Increased Protein Glycation in Cirrhosis and Therapeutic Strategies to Prevent It
AHMED, N., LÜTHEN, R., HÄUSSINGER, D., ŠEBEKOVÁ, K., SCHINZEL, R., VOELKER, W., HEIDLAND, A., & THORNALLEY, P. J. (2005) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1333.083 · Cited by 26
Self-citationTeichert, T., Hellwig, A., Peßler, A., Hellwig, M., Vossoughi, M., Sugiri, D., Vierkötter, A., Schulte, T., Freund, J., Roden, M., et al. (2015) · PLOS ONE · doi:10.1371/journal.pone.0128293 · Cited by 20
“Compared to previous works we observed overall lower AGE levels [23] as well as lower concentrations for α-dicarbonyl compounds, but higher levels for 3-DF in plasma compared to previous studies [34, 35].”
MethodResultBuetler, T. M., Latado, H., Leclerc, E., Weigle, B., Baumeyer, A., Heizmann, C. W., & Scholz, G. (2011) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201000140 · Cited by 13
Metadata
- Authors
- THORNALLEY, P. J., BATTAH, S., AHMED, N., KARACHALIAS, N., AGALOU, S., BABAEI-JADIDI, R., & DAWNAY, A.
- Venue
- Biochemical Journal
- Publisher
- Portland Press Ltd.
- Published
- 2003-11-01
- Volume
- 375
- Issue
- 3
- Pages
- 581-592
- ISSN
- 0264-6021 (ISSN-L)
- 1470-8728
- OpenAlex
- W1994051814
- Cited by
- 659
- References
- 35
- FWCI
- 14.26
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.